Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities

Life Sciences 2026

View at publisher
Authors: Ayman Ali Mohammed Alameen, Hayder M Al-Kuraishy, Ahmed M. Abdelaziz, Ali I. Al-Gareeb, Ali K. Albuhadily, Gaber El-Saber Batiha
DOI: 10.1016/j.lfs.2026.124578
Cited by: 1
References: 85

Fields of Study & Subjects

PARP inhibition in cancer therapy Alzheimer's disease research and treatments Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
Life Sciences
Publisher
Elsevier BV
Volume
402
Pages
124578–124578
Publication date
7 July 2026
Language
EN